ArticleUltrasonics sonochemistry2025
Effect of vortex fluidic device and its combined treatment with ultrasonication on the conformational changes of soy protein isolate.
Article in Ultrasonics sonochemistry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Enhancing the functional properties of Soy Protein Isolate (SPI) is critical for its effective application in the food industry. The present study explored SPI modification through twomethods: (1) varying the rotational speed of a Vortex Fluidic Device (VFD) between 2000 and 8000 rpm, and (2) integrating Ultrasound (US) treatment (40 kHz, 220 V; 10-50 min) in combination with VFD operation at 8000 rpm. VFD treatment reduced substantial particle size (from 1732 nm to 591.6 nm) and increased the denaturation temperature (Tp) to 109.56 °C, indicating enhanced thermal stability. While the secondary structure was largely stable, a specific conformational shift occurred at VFD6000, marked by a ∼6.7 % decrease in β-turns and a ∼2.9 % increase in β-sheets. In contrast, the synergistic USVFD treatment induced more pronounced structural changes; the US30VFD8000 condition increased β-sheet content by ∼7.4 % and promoted re-aggregation (particle size ∼761.5 nm vs. 623.1 nm for VFD8000), albeit with a slight reduction in Tp to 107.79 °C. Thermogravimetric analysis (TGA) confirmed that USVFD accelerated degradation, increasing mass loss to ∼36.7 % (vs. ∼29.4 % for native SPI) and reducing final residue to ∼21.2 % (vs. ∼25.3 % for VFD8000). SEM imaging clearly illustrated these trends, revealing fragmented structures after VFD and uniform aggregates with clusters following USVFD treatment. These findings demonstrate that VFD treatment primarily unfolds and fragments SPI, while USVFD promotes re-aggregation into a modified structure. This provides a strategic basis for tailoring SPI functionality, VFD for thermal stability and USVFD for improved hydration, enabling targeted applications in food design.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.